BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES

MINNEAPOLIS, Feb. 14, 2023 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and Cell Signaling Technology (CST) announced today the addition of Simple Western™ validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular…

About the Author

has written 41558 stories on this site.

Copyright © 2010 Business and Corporate News.